Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Capital Expenditures (2018 - 2025)

Select Medical Holdings (SEM) has disclosed Capital Expenditures for 7 consecutive years, with $59.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Capital Expenditures rose 143.15% to $59.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $229.2 million, a 952.26% increase, with the full-year FY2025 number at $229.2 million, up 952.26% from a year prior.
  • Capital Expenditures was $59.1 million for Q4 2025 at Select Medical Holdings, up from $53.1 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $64.7 million in Q2 2025 to a low of -$150.2 million in Q4 2023.
  • A 5-year average of $25.1 million and a median of $50.4 million in 2023 define the central range for Capital Expenditures.
  • Peak YoY movement for Capital Expenditures: crashed 251.57% in 2022, then surged 143.15% in 2025.
  • Select Medical Holdings' Capital Expenditures stood at $55.2 million in 2021, then plummeted by 251.57% to -$83.6 million in 2022, then plummeted by 79.68% to -$150.2 million in 2023, then grew by 8.81% to -$137.0 million in 2024, then soared by 143.15% to $59.1 million in 2025.
  • Per Business Quant, the three most recent readings for SEM's Capital Expenditures are $59.1 million (Q4 2025), $53.1 million (Q3 2025), and $64.7 million (Q2 2025).